FB pixel
Request Support
Request Info
Resources|Resource Type|Case Studies|Xstrahl in Action: Xstrahl 300 Used to Treat NMSC with Hypofractionated Radiotherapy

Xstrahl in Action: Xstrahl 300 Used to Treat NMSC with Hypofractionated Radiotherapy

January 26, 2021

This study, Hypofractionated Radiotherapy in Older Patients with Non-melanoma Skin Cancer: Less is Better, explores how our Xstrahl 300 system was used to successfully treat NMSC for 3 older patients. See the full study here, and more details below.

Contact Us

Find out more about how Xstrahl will work tirelessly for you

Contact Us

Explore Related Posts

Xstrahl to Highlight Superficial and Orthovoltage Radiotherapy Solutions for Skin Cancer and Selective Benign Conditions at ACRO Summit 2025 in Las Vegas

Xstrahl to Highlight Superficial and Orthovoltage Radiotherapy Solutions for Skin Cancer and Selective Benign Conditions at ACRO Summit 2025 in Las Vegas

Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Xstrahl 200, a modern orthovoltage radiotherapy solution for treating superficial lesions, skin cancers, and selective benign conditions. Visit Xstrahl at booth 220 at the ACRO Summit 2025 – The Radiation Oncology Summit located at Planet Hollywood, Las Vegas, NV from March 12-15, 2025.

read more